CARs: Synthetic Immunoreceptors for Cancer Therapy and Beyond.

ABSTRACT: Chimeric antigen receptors (CARs) are versatile synthetic receptors that provide T cells with engineered specificity. Clinical success in treating B-cell malignancies has demonstrated the therapeutic potential of CAR-T cells against cancer, and efforts are underway to expand the use of engineered T cells to the treatment of diverse medical conditions, including infections and autoimmune diseases. Here, we review current understanding of the molecular properties of CARs, how this knowledge informs the rational design and characterization of novel receptors, the successes and shortcomings of CAR-T cells in the clinic, and emerging solutions for the continued improvement of CAR-T cell therapy.

SUBMITTER: Chang ZL 

PROVIDER: S-EPMC5423782 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature